References
- Saraiva MJ, Birken S, Costa PP, Goodman DS. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest 1984;74:104–119.
- Saraiva MJ. Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat 2001;17:493–503.
- Coimbra A, Andrade C. Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. I. Interstitial changes. Brain 1971;94:199–206.
- Sousa A, Coelho T, Barros J, Sequeiros J. Anticipation in familial amyloid neuropathy type I (FAP-I): the possible role of a genetic modifier. J Neurol 1995;S1:48.
- Sequeiros J, Saraiva MJ. Onset in the seventh decade and lack of symptoms in heterozygotes for the TTRMet30 mutation in hereditary amyloid neuropathy-type I (Portuguese, Andrade). Am J Med Genet 1987;27:345–357.
- Coelho T, Sousa A, Lourenço E, Ramalheira J. A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J Med Genet 1994;31:293–299.
- Coutinho P, Martins da Silva A, Lopes Lima J. Forty years of experience with type I amyloid neuropathy: review of 438 cases. Amyloid and amyloidosis. Amsterdam: Excerpta Medica 1980:88–98.
- Said G, Ropert A, Faux N. Length-dependent degeneration of fibers in Portuguese amyloid polyneuropathy: a clinicopathologic study. Neurology 1984;34:1025–1032.
- Monteiro JG. The digestive system in familial amyloidotic polyneuropathy. Am J Gastroenterol 1973;60:47–59.
- Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994;235:479–485.
- Delahaye N, Dinanian S, Slama MS, Mzabi H, Samuel D, Adams D, Merlet P, Le Guludec D. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med 1999;26:416–424.
- Ando Y, Araki S, Shimoda O, Kano T. Role of autonomic nerve functions in patients with familial amyloidotic polyneuropathy as analyzed by laser Doppler flowmetry, capsule hydrograph, and cardiographic R-R interval. Muscle Nerve 1992;15:507–512.
- Correia MJ, Coutinho CA, Conceição I, Almeida A, Cantinho G, Bordalo e Sá A, Oliveira, E, et al. Role of heart rate variability in the assessment of autonomic dysfunction in type I familial amyloidotic polyneuropathy. Folia Cardiol 2005;12:459–462.
- Lobato L, Beirão I, Silva M, Bravo F, Silvestre F, Guimarães S, Sousa A, et al. Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy. Nephrol Dial Transplant 2003;18:532–538.
- Lobato L, Ventura A, Beirão I, Miranda HP, Seca R, Henriques AC, Teixeira M, et al. End-stage renal disease in familial amyloidosis ATTR Val30Met: a definitive indication to combined liver-kidney transplantation. Transplant Proc 2003;35:1116–1120.
- Ando E, Ando Y, Okamura R, Uchino M, Ando M, Negi A. Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up. Br J Ophthalmol 1997;81:295–298.